John C. McKew Insider Trading
Get free email notifications about insider trading for John C. McKew.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John C. McKew. John C. McKew is a Chief Scientific Officer in LUMOS PHARMA, INC. ($NLNK) and a Vice President, Research in aTYR PHARMA INC ($LIFE) and a VP, Research in aTYR PHARMA INC ($LIFE).
Address: C/O ATYR PHARMA, INC. 3545 JOHN HOPKINS COURT, SUITE #250 SAN DIEGO 92121 CA
Companies in which John C. McKew is an Insider
aTYR PHARMA INC
Trading Symbol: LIFEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John C. McKew: VP, Research, Vice President, Research
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2016
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUMOS PHARMA, INC.
Trading Symbol: NLNKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John C. McKew: Chief Scientific Officer
Holdings: 13,226 shares
Current Value: $180,799
Latest Transaction: Apr 05 2021
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John C. McKew
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Payment of Exercise | F | 12.25 | 1,036 | 12,691 | 13,226 | 14.3 K to 13.2 K (-7.26 %) |
Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Option Exercise | A | 7.87 | 65,000 | 511,550 | 65,000 | |
Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Grant | A | 0.00 | 13,000 | 0 | 13,000 | 0 to 13 K |
Jan 29 2016 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 6.14 | 40,000 | 245,600 | 40,000 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 9.13 | 25,913 | 236,586 | 25,913 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 10.24 | 11,337 | 116,091 | 11,337 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 10.24 | 23,000 | 235,520 | 23,000 |